Cardiomyopathies: from genetics to the prospect of treatment
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 358 (9293) , 1627-1637
- https://doi.org/10.1016/s0140-6736(01)06657-0
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- The heart failure epidemic: exactly how big is it?European Heart Journal, 2001
- The Genetic Basis for Cardiomyopathy: from Mutation Identification to Mechanistic ParadigmsPublished by Elsevier ,2001
- Underlying Causes and Survival in Patients with Heart FailureNew England Journal of Medicine, 2000
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996
- Heart failure: a growing public health problemJournal of Internal Medicine, 1995
- Spectrum and outcome of congestive heart failure in a hospitalized populationAmerican Heart Journal, 1993
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987